ataxin intermediate-length polyglutamine expansions associated increased risk als
causes amyotrophic lateral sclerosis als devastating human neurodegenerative disease poorly understood although protein tdp suggested critical role disease pathogenesis show ataxin atxn2 polyglutamine polyq protein mutated spinocerebellar ataxia type potent modifier tdp toxicity animal cellular models atxn2 tdp associate complex depends rna spinal cord neurons als patients atxn2 abnormally localized likewise tdp shows mislocalization spinocerebellar ataxia type assess involvement atxn2 als analysed length polyq repeat atxn2 gene als patients found intermediate-length polyq expansions glutamines atxn2 significantly associated als data establish atxn2 relatively common als susceptibility gene furthermore findings indicate tdp--atxn2 interaction may promising target therapeutic intervention als tdp proteinopathies
